Prospective comparative study between new and original approach for prevention of LFCN injury in THA with DAA
Not Applicable
Recruiting
- Conditions
- Hip joint disease
- Registration Number
- JPRN-UMIN000035944
- Lead Sponsor
- Juntendo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.previous hip surgery (THA revision, osteotomy) 2.septic arthritis 3.patients who don't observe doctoers' indication or can't observe because of mental disorder 4.severe obesity (BMI over 35) 5.patients who were judged as unsuitable
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method part of that feel discomfort details of discomfort movement of that feel discomfort presence or absence of symptom degree of symptom lost time of symptom
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie LFCN injury in THA with DAA and how might they inform prevention strategies?
How does the new approach in JPRN-UMIN000035944 compare to standard-of-care techniques in reducing LFCN injury during THA with DAA?
Are there specific biomarkers that can identify patients at high risk for LFCN injury in THA with DAA procedures?
What are the potential adverse events associated with the new LFCN injury prevention approach in JPRN-UMIN000035944 and how are they managed?
What alternative or combination therapies are being explored alongside LFCN injury prevention in THA with DAA procedures?